• Latest Posts
In Depth 2 Nov 2023

How French pharma giant Sanofi is betting big on AI

In Depth 30 Oct 2023

The ongoing search for an HIV cure: can CRISPR crack the code?

In Depth 27 Oct 2023

Big pharma monopolies: major antitrust cases over the past decade

In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

In Depth 20 Oct 2023

Is Africa ready to become the next big biopharma and vaccine manufacturing destination?

In Depth 19 Oct 2023

Biotech’s battle against NASH: The ongoing pursuit of an effective treatment

ADVERTISEMENT
In Depth 16 Oct 2023

Blockchain-based biotech: is this a viable financing method?

In Depth 13 Oct 2023

How close are we to a cure for metastatic breast cancer?

In Depth 12 Oct 2023

Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?

In Depth 11 Oct 2023

Project NextGen: The U.S. government’s $5 billion initiative to stay one step ahead of COVID-19

In Depth 9 Oct 2023

The biggest private biotech investments in September 2023

In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?  

ADVERTISEMENT